Kindstar Globalgene Technology
Latest round
- Series E
Last raised
- Dec 2020
Total raised
- $187M
Investors
- 14
About Kindstar Globalgene Technology
, also known as Kindstar, is an esoteric testing service provider that provides specialized diagnosis, treatment, and personalized medicine services. Kindstar provides specialized laboratories for testing and testing platforms such as PCR (real-time PCR) platform, gene chip platform (Affymetrix), liquid chip platform (Luminex), mass spectrometry platform (Sequenom), digital gene platform (NanoString), and other types of clinical pathology and testing platform. As of 2021, the company has 38,000 square meters of clinical testing and R&D center in Beijing, Shanghai, Wuhan, Xinjiang, Chengdu, and Tianjin in China.
Who invested in Kindstar Globalgene Technology
14 investors across 6 rounds
See all investors in Kindstar Globalgene Technology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kindstar Globalgene Technology
Who invested in Kindstar Globalgene Technology?
Kindstar Globalgene Technology has 14 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kindstar Globalgene Technology raised?
Kindstar Globalgene Technology has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Kindstar Globalgene Technology last raise money?
Kindstar Globalgene Technology's most recent round on record is a Series E, in Dec 2020.
What does Kindstar Globalgene Technology do?
, also known as Kindstar, is an esoteric testing service provider that provides specialized diagnosis, treatment, and personalized medicine services.
Where is Kindstar Globalgene Technology headquartered?
Kindstar Globalgene Technology is headquartered in Wuhan, China.
Which VCs invest in companies like Kindstar Globalgene Technology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Kindstar Globalgene Technology's stage. Their profiles are linked below.
VCs backing healthcare startups at Series E
Raising like Kindstar Globalgene Technology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.